Posts Tagged ‘Publications’
C. Renou, B. Lesgourgues, G. Macaigne, A. Pauwels, Y. Le Bricquir, J. Henrion, F. Khemissa, E. Clair, T. Paupard, A. Pelaquier, H. Agostini, A.M. Roque-Afonso. Hepatitis E in decompensated alcoholic cirrhosis. Hepatology 2017 Jan;65(1):388-389. doi: 10.1002/hep.28792
H Neffatti, P Lebraud, C Hottelet, J Gharbi, T Challouf, AM Roque-Afonso. Southern Tunisia: a still high endemicity area for Hepatitis A. PLoS One 2017
P Ndumbi, G. S. Freidl, C. Williams, O. Mardh, C. Varela, A. Avellón, I. Friesema, H. Vennema, K. Beebeejaun , S. L. Ngui, M. Edelstein, A. Smith-Palmer, N. Murphy, J. Dean, M. Faber, J. Wenzel, M. Kontio, L. Müller, S. Midgley, L. Sundqvist, J. Ederth, A. Roque-Afonso, E. Couturier, S. Klamer, J. Rebolledo, V. Suin, S. W. Aberle, D. Schmid, R. de Sousa, G. F. Augusto, V. Alfonsi, M. Del Manso, A. Ciccaglione, K. Mellou, C. Hadjichristodoulou, A. Donachie, M. Borg, M. Sočan, M. Poljak, Ettore Severi and The European Hepatitis A outbreak team. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area (EU/EEA), June 1st 2016 – May 31st 2017. Eurosurveill.
Alnuaimi K, Lavolé J, Lascoux-Combes C, Roque-Afonso AM, Sogni P, Pol S, Mallet V. Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine. Hepatology, 2017 Dec 1. doi: 10.1002/hep.29697. [Epub ahead of print].
Bisseux M, Colombet J, Mirand A, Roque-Afonso AM, Abravanel F, Izopet J, Archimbaud C, Peigue-Lafeuille H, Debroas D, Bailly JL, Henquell C. Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: results of a one-year experiment in Central France, 2014-2015. Eurosurveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00237
Charre C, Ramière C, Roque-Afonso AM, Chidiac C, Zoulim F, Godinot M, Koffi J, Scholtès C, Livrozet JM, HAV Lyon Study Group, Cotte L. HAV outbreak in French HIV-infected MSM and PrEP users despite a high immunization rate. Eurosurveill. Euro Surveill. 2017 Nov;22(48). doi: 10.2807/1560-7917.ES.2017.22.48.17-00742
Mallet V, Bruneau J, Zuber J, Alanio C, Leclerc-Mercier S, Roque-Afonso AM, Kraft ARM, Couronné L, Roulot D, Wedemeyer H, Albert ML, Hillon P, Laroche L, Pol S, Hermine O.Hepatitis E Virus-Induced Primary Cutaneous CD30(+) T cell Lymphoproliferative Disorder. J Hepatol. 2017 Aug 28. pii: S0168-8278(17)32250-X. doi: 10.1016/j.jhep.2017.08.011
Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V. Chronic hepatitis E in HIV/HBV coinfectde patient: lack of power of sofosbuvir-ribavirin. AIDS. 2017 Jun 1;31(9):1346-1348.
H Neffatti, P Lebraud, C Hottelet, J Gharbi, T Challouf, AM Roque-Afonso. Southern Tunisia: a still high endemicity area for Hepatitis A. PLoS One 2017 Apr 20;12(4):e0175887. doi: 10.1371/journal.pone.0175887. eCollection 2017.
S. Lhomme, L. Bardiaux, F. Abravanel, P. Gallian, N.Kamar, J. Izopet. Hepatitis E virus infection in solid organ transplant recipients, France. Emerging Infectious Diseases 2017;23:353-356.
M. Carré, A. Thiebaut-Bertrand, S. Larrat, V. Leroy, P. Pouzol, N. Sturm, S. Lhomme, JY. Cahn, F. Garban, P. Morand. Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation. Bone Marrow Transplantation 2017;1-3.
Donnelly MC, SN. Imlach, F. Abravanel, S. Ramalingam, I. Johannessen, J. Petrik, AR. Fraser, JD. Campbell, P. Bramley, HR. Dalton, PC. Hayes, N. Kamar, KJ. Simpson. Sofosbuvir and Daclatasvir anti-viral therapy fails to clear HEV viremia and restore reactive T cells in a HEV/HCV co-infected liver transplant recipient. Gastroenterology 2017;152:300-301.
Abravanel F, S. Lhomme, M. Fougère, K. Sauné, M. Alvarez, JM. Péron, P. Delobel, J. Izopet. HEV infection in French HIV-infected patients. Journal of Infection 2017;74:310-313.
Abravanel F, N. Goutagny, C. Perret, S. Lhomme, F. Vischi, A. Aversenq, A. Chapel, N. Dehainault, N. Piga, J. Dupret-Carruel, J. Izopet. Evaluation of two VIDASÒ prototypes for detecting anti-HEV IgG. Journal of Clinical Virology 2017;89:46-60.
HR. Dalton, JJJ. Van Eijk, P. Cintas, RG. Madden, CJ. Jones, GW. Webb, B. Norton, J. Pique, S. Lutgens, N. Devooght-Johnson, K. Woolson, J. Baker, M. Saunders, L. Househam, J. Griffiths, F. Abravanel, J. Izopet, N. Kamar, N. van Alfen, BG. Van Engelen, JG. Hunter, AA. van der Eijk, RP. Bendall, BN. Mclean, BC. Jacobs. Hepatitis E virus infection and acute non-traumatic neurological injury: a prospective pilot multicentre study. Journal of Hepatology 2017;67:925-932.
J. Belliere, F. Abravanel, MB. Nogier, S. Martinez, P. Cintas, S. Lhomme, L. Lavayssière, O. Cointault, S. Faguer, J. Izopet, N. Kamar. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart-transplant patient. Transplant Infectious Disease 2017;19:6.
A Velay, W. Kack-Kack, F. Abravanel, S. Lhomme, P. Leyendecker, L. Kremer, P. Chamouard, J. Izopet, S. Fafi-Kremer, H. Barth. Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient. Journal of Neurovirology 2017;23:615-620.
S. Chapuy-Regaud, M. Dubois, C. Plisson-Chastang, T. Bonnefois, S. Lhomme, J. Bertrand-Michel, B. You, S. Simoneau, PE. Gleizes, B. Flan, F. Abravanel, J. Izopet. Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response. Biochimie 2017;141:70-79.
JJJ. van Eijk, HR. Dalton, P. Ripellino, RG. Madden, CJE. Jones, M. Fritz, C. Gobbi, G. Melli, E. Pasi, J. Herrod, RF. Lissmann, HH. Ashraf, M. Abdelrahim, O. Almasri, M. Fraga, D. Benninger, T. Kuntzer, V. Aubert, R. Sahli, D. Moradpour, H. Blasco-Perrin, S. Attarian, R. Gerolami, P. Colson, MT. Giordani, J. Hartl, S. Pischke, NX. Lin, BN. Mclean, RP. Bendall, M. Panning, JM. Peron, N. Kamar, J. Izopet, BC. Jacobs, N. van Alfen, BGM. van Engelen. Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international multicenter retrospective comparative study. Neurology 2017:909-917.
F. Abravanel, S. Lhomme, H. El Costa, B. Schvartz, JM. Peron, N. Kamar, J. Izopet. Rabbit Hepatitis E virus infections in humans, France. Emerging Infectious Diseases 2017;23:1191-1193.
H. Barragué, B. Condat, N. Petitdidier, E. Champagne, C. Renou, J. Izopet, F. Abravanel. Chronic hepatitis E virus infection in a cirrhotic patient: a case report. Medicine 2017;96 :e7915.
IM Sayed, L. Foquet, L. Verhoye, F. Abravanel, A. Farhoudi, G. Leroux-Roels, J. Izopet, P. Meuleman. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Research 2017 141:150-154.
IM. Sayed, L. Verhoye, L. Cocquerel, F. Abravanel, L. Foquet, C. Montpellier, Y. Debing, A. Farhoudi, C. Wychowski, J. Dubuisson, G. Leroux-Roels, J. Neyts, J. Izopet, T. Michiels, P. Meuleman. Study of Hepatitis E virus infection of genotype 1 and 3 in mice with humanized liver. Gut 2017;66:920-929.
N. Kamar, J. Izopet, N. Pavio, R. Agarwal, A. Labrique, H. Wedemeyer, H. Dalton. Hepatitis E virus infection. Nature Reviews Disease Primers 2017;3 :17086
X. Yin, X. Li, C. Ambardekar, Z. Hu, S. Lhomme, Z. Feng. Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog. 2017 May 30;13(5):e1006417.
V Mallet; R Sberro-Soussan, A Vallet-Pichard, AM Roque-Afonso, S Pol. Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report. Ann Intern Med 2016, 21;164(12):851-2. doi: 10.7326/L15-0502.
Pourbaix A, Ouali N, Soussan P, Roque-Afonso AM, Péraldi MN, Rondeau E, Peltier J. Evidence of hepatitis E virus transmission by renal graft. Transpl Infect Dis. 2016 Oct 24. doi: 10.1111/tid.12624
De Martin E, Antonini TM, Coilly A, Pittau G, Vibert E, Duclos-Vallée JC, Samuel D, Roque-Afonso AM. HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses. Transplant International Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898
R. Boudjellil, M. Elbaz, O. Lairez, J. Izopet, N. Kamar. No evidence of genotype-3 hepatitis E virus-induced myocarditis. Journal of Clinical Virology 2016;76:44.
Y. Guillois, F. Abravanel, T. Miura, N. Pavio, V. Vaillant, S. Lhomme, F.S. Le Guyader, N. Rose, JC. Le Saux, L. King, J. Izopet, E. Couturier. High proportion of asymptomatic infections in an outbreak of hepatitis E associated with a spit-roasted piglet, France, 2013. Clinical Infectious Diseases 2016;62:351-357.
J. Petrik, M. Lozano, CR. Seed, HM. Faddy, AJ. Keller, PS. Prado Scuracchio, S. Wendel, A. Andonov, M. Fearon, G. Delage, J. Zhang, JW. Shih, P. Gallian, R. Djoudi, P. Tiberghein, J. Izopet, J. Dreier, T. Vollmer, C. Knabbe, R. Aggarwal, A. Goel, AR. Ciccaglione, K. Matsubayashi, M. Satake, K. Tadokoro, SH. Jeong, HL. Zaaijer, E. Zhiburt, J. Chay, D. Teo, SS. Chua, M. Piron, S. Sauleda, JM. Echevarria, H. Dalton, SL. Stramer. Hepatitis E. Vox Sanguinis 2016;110 :93-103.
N. Kamar, O. Marion, J. Izopet. When should ribavirin be started to treat hepatitis E virus infection in transplant-patients? American Journal of Transplantation 2016;16:727.
JM. Péron, F. Abravanel, M. Guillaume, R. Gérolami, J. Nana, R. Anty, A. Pariente, C. Renou, C. Bureau, MA. Robic, L. Alric, JP. Vinel, J. Izopet, N. Kamar. Treatment of autochtonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Liver International 2016;36:328-333.
P. Trémeaux, S. Lhomme, S. Chapuy-Regaud, JM. Peron, L. Alric, N. Kamar, J. Izopet, F. Abravanel. Performance of an antigen assay for the diagnosis of acute hepatitis E virus infection. Journal of Clinical Virology 2016;79:1-5.
Guinault D, Ribes D, Delas A, Milongo D, Abravanel F, Puissant-Lubrano B, Izopet J, Kamar N. Hepatitis E Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person.Am J Kidney Dis. 2016 Apr;67(4):660-3
Abravanel F, Barragué H, Dörr G, Sauné K, Péron JM, Alric L, Kamar N, Izopet J, Champagne E. Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. J Infect. 2016 :723-30.
Smith DB, Simmonds P, Izopet J, Oliveira-Filho EF, Ulrich RG, Johne R, Koenig M, Jameel S, Harrison TJ, Meng XJ, Okamoto H, Van der Poel WH, Purdy MA. Proposed reference sequences for hepatitis E virus subtypes.J Gen Virol. 2016 Mar;97(3):537-42
Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, Morel P, Legrand D, Tiberghien P, Izopet J.A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology. 2016 Apr;63(4):1145-54
Servant-Delmas A, Abravanel F, Lefrère JJ, Lionnet F, Hamon C, Izopet J, Laperche S. New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France. J Viral Hepat. 2016 Jul;23(7):569-75.
Miura T, Lhomme S, Le Saux JC, Le Mehaute P, Guillois Y, Couturier E, Izopet J, Abravanel F, Le Guyader FS. Detection of hepatitis E virus in sewage after an outbreak on a French Island. Food and Environmental Virology 2016 ;8 :194-199.
Sayed IM, Verhoye L, Cocquerel L, Abravanel F, Foquet L, Montpellier C, Debing Y, Farhoudi A, Wychowski C, Dubuisson J, Leroux-Roels G, Neyts J, Izopet J, Michiels T, Meuleman P.Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 2016 Ma 22
Nicot F, M. Cazabat, S. Lhomme, O. Marion, K. Sauné, J. Chiabrando, M. Dubois, N. Kamar, F. Abravanel, J. Izopet. Quantification of HEV RNA by Droplet Digital PCR. Viruses 2016;8:8.
A.Brown, JS. Halliday, L. Swadling, R. Madden, R. Bendall, JG. Hunter, J. Maggs, P. Simmonds, DB. Smith, L. Vine, C. McLaughlin, J. Collier, K. Jeffery, P. Klenerman, J. Izopet, N. Kamar, HR. Dalton, E. Barnes. Characterisation of the specificity, functionality and durability of host T-cell responses against the full-length hepatitis E virus. Hepatology 2016 ;64:1934-1950.
Revues:
Marion O, Abravanel F, Lhomme S, Izopet J, Kamar N. Hepatitis E in transplantation. Curr Infect Dis Rep 2016:18:8.
Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR. Extrahepatic manifestations of hepatitis E virus. Liver Int 2016;36:467-72.
Blasco-Perrin H, Abravanel F, Blasco-Baque V, Péron JM. Hepatitis E, the neglected one. Liver Int 2016 Jan;36 Suppl 1:130-4.
N. Kamar, O. Marion, J. Izopet. When should ribavirin be started to treat hepatitis E virus infection in transplant-patients? American Journal of Transplantation 2016;16:727.
Kamar N, S. Lhomme, F. Abravanel, O. Marion, JM. Péron, L. Alric, J. Izopet. Treatment of HEV infection in patients with a solid-organ transplant and chronic hepatitis. Viruses 2016;8:8.
S. Lhomme, O. Marion, F. Abravanel, S. Chapuy-Regaud, N. Kamar, J. Izopet. Hepatitis E pathogenesis. Viruses 2016;8:8.
Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France.Lhomme S, Abravanel F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.Infect Genet Evol. 2015 Oct;35:50-5. doi: 10.1016/j.meegid.2015.07.028. Epub 2015 Jul 26.
Treatment of autochthonous acute hepatitis e with short term ribavirin: a multicenter retrospective study. Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N. Liver Int. 2015 Jul 14. doi: 10.1111/liv.12911.
Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J.Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742.
Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J.Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005.
[Treatment of hepatitis E virus infection]. Kamar N, Rostaing L, Alric L, Peron JM, Izopet J.Presse Med. 2015 Mar;44(3):339-42. doi: 10.1016/j.lpm.2014.10.011. Epub 2015 Jan 29. Review. French.
[Hepatitis E virus]. Izopet J, LhommeS, Abravanel F, Roque AM, Kamar N. Presse Med. 2015 Mar;44(3):328-32. doi: 10.1016/j.lpm.2014.11.004. Epub 2015 Jan 30. Review. French
Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin. Del Bello A, Guilbeau-Frugier C, Josse AG, Rostaing L, Izopet J, Kamar N.Transpl Infect Dis. 2015 Apr;17(2):279-83. doi: 10.1111/tid.12353. Epub 2015 Feb 24
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, Chatelus E, Claudepierre P, Hudry C, Izopet J, Fabre S, Lefevre G, Marguerie L, Martin A, Messer L, Molto A, Pallot-Prades B, Pers YM, Roque-Afonso AM, Roux C, Sordet C, Soubrier M, Veissier C, Wendling D, Péron JM, Sibilia J; Club Rhumatismes et Inflammation, a section of the French Society of Rheumatology. Medicine (Baltimore). 2015 Apr;94(14):e675. doi: 10.1097/MD.0000000000000675.
Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.Mansuy JM, Saune K, Rech H, Abravanel F, Mengelle C, L Homme S, Destruel F, Kamar N, Izopet J.Euro Surveill. 2015 May 14;20(19):27-34.
Wildlife Reservoir for Hepatitis E Virus, Southwestern France.Lhomme S, Top S, Bertagnoli S, Dubois M, Guerin JL, Izopet J.Emerg Infect Dis. 2015 Jul;21(7):1224-6. doi: 10.3201/eid2107.141909.
Treatment of autochthonous acute hepatitis e with short term ribavirin: a multicenter retrospective study. Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N.Liver Int. 2015 Jul 14. doi: 10.1111/liv.12911.
Hepatitis E. Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL.Vox Sang. 2015 Jul 21. doi: 10.1111/vox.12285.
An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau-Desangles I, Del Bello A, Dörr G, Lavayssière L, Nogier MB, Guitard J, Ribes D, Goin AL, Broué P, Metsu D, Sauné K, Rostaing L, Izopet J.Transplantation. 2015 Oct;99(10):2124-31. doi: 10.1097/TP.0000000000000850.
Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France.Lhomme S, Abravanel F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.Infect Genet Evol. 2015 Oct;35:50-5. doi: 10.1016/j.meegid.2015.07.028. Epub 2015 Jul 26.
Variability and pathogenicity of hepatitis E virus genotype 3 variants.Smith DB, Ijaz S, Tedder RS, Hogema B, Zaaijer HL, Izopet J, Bradley-Stewart A, Gunson R, Harvala H, Kokki I, Simmonds P.J Gen Virol. 2015 Nov;96(11):3255-64. doi: 10.1099/jgv.0.000264. Epub 2015 Aug 14.
Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.Izopet J, Labrique AB, Basnyat B, Dalton HR, Kmush B, Heaney CD, Nelson KE, Ahmed ZB, Zaman K, Mansuy JM, Bendall R, Sauné K, Kamar N, Arjyal A, Karkey A, Dongol S, Prajapati KG, Adhikary D. J Clin Virol. 2015 Sep;70:39-42. doi: 10.1016/j.jcv.2015.06.103. Epub 2015 Jun 29.
Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. J Clin Virol. 2015 Sep;70:101-4. doi: 10.1016/j.jcv.2015.07.302. Epub 2015 Jul 26
High Proportion of Asymptomatic Infections in an Outbreak of Hepatitis E Associated With a Spit-Roasted Piglet, France, 2013. Guillois Y, Abravanel F, Miura T, Pavio N, Vaillant V, Lhomme S, Le Guyader FS, Rose N, Le Saux JC, King LA, Izopet J, Couturier E.Clin Infect Dis. 2015 Oct 1. pii: civ862.
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Perrin HB, Cintas P, Abravanel F, Gérolami R, d’Alteroche L, Raynal JN, Alric L, Dupuis E, Prudhomme L, Vaucher E, Couzigou P, Liversain JM, Bureau C, Vinel JP, Kamar N, Izopet J, Peron JM. Emerg Infect Dis. 2015 Nov;21(11). doi: 10.3201/eid2111.141789. No abstract available.
Hepatitis E virus in hematopoietic stem cell donors: Towards a systematic HEV screening of donors? Frange P, Roque-Afonso AM, Neven B, Moshous D, Touzot F, Cavazzana M, Fischer A, Leruez-Ville M, Blanche S.J Infect. 2015 Jul;71(1):141-4. doi: 10.1016/j.jinf.2015.02.008. Epub 2015 Feb 26.
Multistate foodborne hepatitis A outbreak among European tourists returning from Egypt–need for reinforced vaccination recommendations, November 2012 to April 2013. Sane J, MacDonald E, Vold L, Gossner C, Severi E; Outbreak Investigation Team.Euro Surveill. 2015 Jan 29;20(4). pii: 21018.
Large and prolonged food-borne multistate hepatitis A outbreak in Europe associated with consumption of frozen berries, 2013 to 2014. Severi E, Verhoef L, Thornton L, Guzman-Herrador BR, Faber M, Sundqvist L, Rimhanen-Finne R, Roque-Afonso AM, Ngui SL, Allerberger F, Baumann-Popczyk A, Muller L, Parmakova K, Alfonsi V, Tavoschi L, Vennema H, Fitzgerald M, Myrmel M, Gertler M, Ederth J, Kontio M, Vanbockstael C, Mandal S, Sadkowska-Todys M, Tosti ME, Schimmer B, O Gorman J, Stene-Johansen K, Wenzel JJ, Jones G, Balogun K, Ciccaglione AR, O’ Connor L, Vold L, Takkinen J, Rizzo C. Euro Surveill. 2015 Jul 23;20(29):21192.
Hepatitis E in developed countries: current status and future perspectives. Dalton HR, Kamar N, Izopet J.Future Microbiol. 2014;9(12):1361-72. doi: 10.2217/fmb.14.89. Review.
Hepatitis E virus infections in blood donors, France.Gallian P, Lhomme S, Piquet Y, Sauné K, Abravanel F, Assal A, Tiberghien P, Izopet J.Emerg Infect Dis. 2014 Nov;20(11):1914-7. doi: 10.3201/eid2011.140516.
[Hepatitis E virus: Blood transfusion implications].Gallian P, Piquet Y, Assal A, Djoudi R, Chiaroni J, Izopet J, Tiberghien P.Transfus Clin Biol. 2014 Nov;21(4-5):173-7. doi: 10.1016/j.tracli.2014.07.007. Epub 2014 Sep 27. Review. French.
Hepatitis A virus subgenotyping based on RT-qPCR assays. Coudray-Meunier C, Fraisse A, Mokhtari C, Martin-Latil S, Roque-Afonso AM, Perelle S.BMC Microbiol. 2014 Nov 25;14:296. doi: 10.1186/s12866-014-0296-1.
Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742. Epub 2014 Sep 23
Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005. Epub 2014 Aug 21
Safety measures to prevent hepatitis E virus transmission by blood transfusion. Laperche S, Izopet J, Lefrère JJ. Transfusion. 2014 Aug;54(8):2134-5. doi: 10.1111/trf.12735.
Characterization of the polyproline region of the hepatitis E virus in immunocompromised patients.Lhomme S, Abravanel F, Dubois M, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.J Virol. 2014 Oct;88(20):12017-25. doi: 10.1128/JVI.01625-14. Epub 2014 Aug 6.
Ribavirin for chronic hepatitis E virus infection. Kamar N, Mallet V, Izopet J. N Engl J Med. 2014 Jun 19;370(25):2447-8. doi: 10.1056/NEJMc1405191.
Hepatitis E infection in patients with severe acute alcoholic hepatitis. Haim-Boukobza S, Coilly A, Sebagh M, Bouamoud M, Antonini T, Roche B, Yordanova O, Savary J, Saliba F, Duclos-Vallee JC, Samuel D, Ichai P, Roque-Afonso AM. Liver Int. 2015 Mar;35(3):870-5. doi: 10.1111/liv.12610.
Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin. Robbins A, Lambert D, Ehrhard F, Brodard V, Hentzien M, Lebrun D, Nguyen Y, Tabary T, Peron JM, Izopet J, Bani-Sadr F. J Clin Virol. 2014 Aug;60(4):422-3. doi: 10.1016/j.jcv.2014.05.003. Epub 2014 May 13
Ribavirin for chronic hepatitis E virus infection in transplant recipients.Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D’Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V.N Engl J Med. 2014 Mar 20;370(12):1111-20. doi: 10.1056/NEJMoa1215246.
Does chronic hepatitis E virus infection exist in immunocompetent patients? Kamar N, Izopet J. Hepatology. 2014 Jul;60(1):427. doi: 10.1002/hep.26927. Epub 2014 May 27.
Prospective study of Hepatitis E Virus infection among pregnant women in France. Renou C, Gobert V, Locher C, Moumen A, Timbely O, Savary J, Roque-Afonso AM; Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux (ANGH). Virol J. 2014 Apr 9;11:68. doi: 10.1186/1743-422X-11-68
Hepatitis E: An emerging infection in high income countries. Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AI, Salmon D. J Clin Virol. 2014 Feb;59(2):81-8.
Should we screen blood products for hepatitis E virus RNA ? Féray C, Pawlotsky JM, Roque-Afonso AM, Samuel D, Dhumeaux D. Lancet. 2014 Jan 18;383(9913):218.
Biphasic hepatitis A with severe cholestasis and thrombocytopenic purpura in an HIV-1-infected male patient. Bani-Sadr F, Chakvetadze C, Galperine T, Lassel L, Bonnard P, Lependeven C, Roque-Afonso AM, Pialoux G. Med Mal Infect. 2014 Jan 13. pii: S0399-077X(13)00341-7.
Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Hauser L, Roque-Afonso AM, Beylouné A, Simonet M, Deau Fischer B, Burin des Roziers N, Mallet V, Tiberghien P, Bierling P. Blood. 2014 Jan 30;123(5):796-7.
Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve to chronic infections. Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Kamar N, Izopet J. J Infect Dis. 2014 Jan 16.
Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, Dubois M, Rostaing L, Izopet J. J Infect Dis. 2014 Jan 15;209(2):300-3.
Hepatitis E virus infection. Kamar N, Dalton HR, Abravanel F, Izopet J. Clin Microbiol Rev. 2014 Jan;27(1):116-38.
Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. J Clin Virol. 2013 Dec;58(4):624-8.
Chronic hepatitis E infection cured by pregnancy. Mallet V, Le Mener S, Roque-Afonso AM, Tsatsaris V, Mamzer MF. J Clin Virol. 2013 Dec;58(4):745-7.
Does chronic hepatitis E virus infection exist in immunocompetent patients? Kamar N, Izopet J. Hepatology. 2013 Nov 9. doi: 10.1002/hep.26927.
Hepatitis C virus infection in nephrology patients. Rostaing L, Izopet J, Kamar N. J Nephropathol. 2013 Oct;2(4):217-233.
Comparison of real-time RT-PCR assays for hepatitis E virus RNA detection. Mokhtari C, Marchadier E, Haïm-Boukobza S, Jeblaoui A, Tessé S, Savary J, Roque-Afonso AM. J Clin Virol. 2013 Sep;58(1):36-40.
[Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient.] Comont T, Bonnet D, Sigur N, Gerdelat A, Legrand-Abravanel F, Kamar N, Alric L. Rev Med Interne. 2013 Sep 27. pii: S0248-8663(13)00529-8.
Genotype 4 hepatitis e virus in france: an autochthonous infection with a more severe presentation. Jeblaoui A, Haim-Boukobza S, Marchadier E, Mokhtari C, Roque-Afonso AM. Clin Infect Dis. 2013 Aug;57(4):e122-6.
Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. Coilly A, Haïm-Boukobza S, Roche B, Antonini TM, Pause A, Mokhtari C, Becq A, Farahmand H, Hauser L, Duclos-Vallée JC, Samuel D, Adam R, Roque-Afonso AM. Transplantation. 2013 Jul 27;96(2):e4-6.
How Should Hepatitis E Virus Infection Be Defined in Organ-Transplant Recipients? Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. Am J Transplant. 2013 May 9. doi: 10.1111/ajt.12253.
An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G, Moradpour D, Abravanel F, Izopet J, Cavassini M, Darling KE. PLoS One. 2013 May 7;8(5):e62980.
World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Baylis SA, Blümel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, Nübling CM, Hanschmann KM; HEV Collaborative Study Group. Emerg Infect Dis. 2013 May;19(5):729-35.
Hepatitis E virus. Abravanel F, Lhomme S, Dubois M, Peron JM, Alric L, Kamar N, Izopet J. Med Mal Infect. 2013 Apr 19.
Hepatitis e virus infection in immunosuppressed patients: natural history and therapy. Kamar N, Rostaing L, Izopet J. Semin Liver Dis. 2013 Feb;33(1):62-70.
Performance of two commercial assays for detecting HEV RNA in acute or chronic infections. Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L,
Rostaing L, Kamar N, Izopet J. J Clin Microbiol. 2013 Mar 20.
Hepatitis E virus infection. Kamar N, Izopet J, Rostaing L. Curr Opin Gastroenterol. 2013 May;29(3):271-8.
Risk of zoonotic transmission of HEV from rabbits. Lhomme S, Dubois M, Abravanel F, Top S, Bertagnoli S, Guerin JL, Izopet J. J Clin Virol. 2013 Mar 6.
Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. Haïm-Boukobza S, Ferey MP, Vétillard AL, Jeblaoui A, Pélissier E, Pelletier G, Teillet L, Roque-Afonso AM. J Hepatol. 2012 Dec;57(6):1374-8.
[Autochthonous hepatitis E: an emerging and still unrecognized disease]. Renou C, Pariente A, Roque-Afonso AM, Nicand E. Rev Prat. 2012 Sep;62(7):903-8.
Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Izopet J, Dubois M, Bertagnoli S, Lhomme S, Marchandeau S, Boucher S, Kamar N, Abravanel F, Guérin JL. Emerg Infect Dis. 2012 Aug;18(8):1274-81.
HEV Quasispecies and the Outcome of Acute Hepatitis E in Solid-Organ Transplant Patients. Lhomme S, Abravanel F, Dubois M, Sandres Saune K, Rostaing L, Kamar N, Izopet J.J Virol. 2012 Jul 3.
Hepatitis E virus and the kidney in solid-organ transplant patients. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. Transplantation. 2012 Mar 27;93(6):617-23.
Genotype 3 diversity and quantification of hepatitis E virus RNA. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. J Clin Microbiol. 2012 Mar;50(3):897-902.
Hepatitis E virus-specific T-cell response after transplantation. Kamar N, Legrand-Abravanel F, Dalton HR, Izopet J. Hepatology. 2012 May;55(5):1643; author reply 1644.
Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt. Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR, El-Daly M, Ibrahim EM, El-Aidy S, Lashin T, El-Hoseiny M, Izopet J, Mohamed MK, Fontanet A, Abdel Hamid M. Clin Microbiol Infect. 2012 Oct;18(10):982-8.
Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. Maylin S, Stephan R, Molina JM, Peraldi MN, Scieux C, Nicand E, Simon F, Delaugerre C. Clin Virol. 2012 Apr;53(4):346-9.
Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus. Arcangeletti MC, Dussaix E, Ferraglia F, Roque-Afonso AM, Graube A, Chezzi C.Clin Vaccine Immunol. 2011 Aug;18(8):1391-4.
Acute pancreatitis: a rare complication of acute hepatitis E.Deniel C, Coton T, Brardjanian S, Guisset M, Nicand E, Simon F. J Clin Virol. 2011 Jul;51(3):202-4.
Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, Sanson-Le-Pors MJ, Bergmann JF, Nicand E. Virol J. 2011 Apr 15;8:171.
Hepatitis A associated with semidried tomatoes, France, 2010. Gallot C, Grout L, Roque-Afonso AM, Couturier E, Carrillo-Santisteve P, Pouey J, Letort MJ, Hoppe S, Capdepon P, Saint-Martin S, De Valk H, Vaillant V. Emerg Infect Dis. 2011 Mar;17(3):566-7.
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Gastroenterology. 2011 May;140(5):1481-9.
Investigation of a severe nosocomial outbreak of hepatitis A among healthcare workers and adult patients. Guet L, Desbois D, Roque-Afonso AM, Germain JM, Merle V. J Hosp Infect. 2011 May;78(1):70-1.
Lethal acute HEV superinfection on hepatitis B cirrhosis. Marion-Audibert AM, Tesse S, Graillot E, Phelip G, Radenne S, Duperret S, Durieux M, Rode A, Mabrut JY, Souquet JC, Nicand E. Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):334-6. doi: 10.1016/j.gcb.2010.02.003. Epub 2010 May 24.
Hepatitis E virus in HIV-infected patients. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allègre T, Poggi C, Pénaranda G, Cordier F, Nicand E; ANGH. AIDS. 2010 Jun 19;24(10):1493-9.
The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos. Syhavong B, Rasachack B, Smythe L, Rolain JM, Roque-Afonso AM, Jenjaroen K, Soukkhaserm V, Phongmany S, Phetsouvanh R, Soukkhaserm S, Thammavong T, Mayxay M, Blacksell SD, Barnes E, Parola P, Dussaix E, Raoult D, Humphreys I, Klenerman P, White NJ, Newton PN. Trans R Soc Trop Med Hyg. 2010 Jul;104(7):475-83.
[Acute myelitis related to hepatitis A after travel to Senegal]. Ficko C, Imbert P, Mechaï F, Barruet R, Nicand E, Rapp C. Med Trop (Mars). 2010 Feb;70(1):7-8.
An oyster-associated hepatitis A outbreak in France in 2007. Guillois-Bécel Y, Couturier E, Le Saux JC, Roque-Afonso AM, Le Guyader FS, Le Goas A, Pernès J, Le Bechec S, Briand A, Robert C, Dussaix E, Pommepuy M, Vaillant V. Euro Surveill. 2009 Mar 12;14(10). pii: 19144.
Hepatitis E, Central African Republic. Escribà JM, Nakoune E, Recio C, Massamba PM, Matsika-Claquin MD, Goumba C, Rose AM, Nicand E, García E, Leklegban C, Koffi B. Emerg Infect Dis. 2008 Apr;14(4):681-3.
A national survey of acute hepatitis E in France. Renou C, Moreau X, Pariente A, Cadranel JF, Maringe E, Morin T, Causse X, Payen JL, Izopet J, Nicand E, Bourlière M, Penaranda G, Hardwigsen J, Gerolami R, Péron JM, Pavio N; ANGH, France. Aliment Pharmacol Ther. 2008 Jun 1;27(11):1086-93.
Acute hepatitis E with severe jaundice: report of three cases. Moucari R, Bernuau J, Nicand E, Cazals-hatem D, Valla D, Marcellin P, Asselah T. Eur J Gastroenterol Hepatol. 2007 Nov;19(11):1012-5.
Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia. Caron M, Enouf V, Than SC, Dellamonica L, Buisson Y, Nicand E. J Clin Microbiol. 2006 Sep;44(9):3440-2.
Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens. Enouf V, Dos Reis G, Guthmann JP, Guerin PJ, Caron M, Marechal V, Nicand E. J Med Virol. 2006 Aug;78(8):1076-82.
A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Guthmann JP, Klovstad H, Boccia D, Hamid N, Pinoges L, Nizou JY, Tatay M, Diaz F, Moren A, Grais RF, Ciglenecki I, Nicand E, Guerin PJ. Clin Infect Dis. 2006 Jun 15;42(12):1685-91.
Viral and clinical factors associated with the fulminant course of hepatitis A infection. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, Dussaix E, Bismuth H, Féray C. Hepatology. 2003 Sep;38(3):613-8.
Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. Costa-Mattioli M, Cristina J, Romero H, Perez-Bercof R, Casane D, Colina R, Garcia L, Vega I, Glikman G, Romanowsky V, Castello A, Nicand E, Gassin M, Billaudel S, Ferré V. J Virol. 2002 Sep;76(18):9516-25.
Identification of a novel hepatitis E virus in Nigeria. Buisson Y, Grandadam M, Nicand E, Cheval P, van Cuyck-Gandre H, Innis B, Rehel P, Coursaget P, Teyssou R, Tsarev S. J Gen Virol. 2000 Apr;81(Pt 4):903-9.
[Fall in the seroprevalence of hepatitis A in French youth]. Joussemet M, Depaquit J, Nicand E, Mac Nab C, Meynard JB, Teyssou R, Fabre G, Buisson Y. Gastroenterol Clin Biol. 1999 Apr;23(4):447-5.